相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris Are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies
Niyati Khetarpal et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Dengue: knowledge gaps, unmet needs, and research priorities
Leah C Katzelnick et al.
LANCET INFECTIOUS DISEASES (2017)
Vaccines licensed and in clinical trials for the prevention of dengue
J. Torresi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
Stephen S. Whitehead et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine
Huabin Liang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Key concepts, strategies, and challenges in dengue vaccine development: an opportunity for sub-unit candidates?
Jian Hang Lam et al.
EXPERT REVIEW OF VACCINES (2016)
Vaccination Against Dengue: Challenges and Current Developments
Bruno Guy et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Edging closer towards the goal of a dengue vaccine
Annelies Wilder-Smith et al.
EXPERT REVIEW OF VACCINES (2016)
The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
Beth D. Kirkpatrick et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Status of vaccine research and development of vaccines for dengue
Kirsten S. Vannice et al.
VACCINE (2016)
Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
Chen-Yi Chiang et al.
SCIENTIFIC REPORTS (2016)
Vaccines and immunization strategies for dengue prevention
Yang Liu et al.
EMERGING MICROBES & INFECTIONS (2016)
Cytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue virus infection
Yuan Tian et al.
FRONTIERS IN IMMUNOLOGY (2016)
Genomic approaches for understanding dengue: insights from the virus, vector, and host
Shuzhen Sim et al.
GENOME BIOLOGY (2016)
Trials and Tribulations on the Path to Developing a Dengue Vaccine
Stephen J. Thomas et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2015)
A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico
Kristen Bauer et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination
J. L. Slon Campos et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
Beth D. Kirkpatrick et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Preventing Dengue - Is the Possibility Now a Reality?
Stephen J. Thomas
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Luis Villar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Next generation dengue vaccines: A review of the preclinical development pipeline
Kirsten S. Vannice et al.
VACCINE (2015)
The dengue vaccine pipeline: Implications for the future of dengue control
Lauren M. Schwartz et al.
VACCINE (2015)
Nucleic acid (DNA) immunization as a platform for dengue vaccine development
Kevin R. Porter et al.
VACCINE (2015)
Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes
Monica Poggianella et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response
Jacky Flipse et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
New insights into the immunopathology and control of dengue virus infection
Gavin Screaton et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Developing a dengue vaccine: progress and future challenges
Stephen J. Thomas
ANTIMICROBIAL THERAPEUTICS REVIEWS: INFECTIOUS DISEASES OF CURRENT AND EMERGING CONCERN (2014)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding et al.
LANCET (2014)
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
Jorge E. Osorio et al.
LANCET INFECTIOUS DISEASES (2014)
Vaccine Development as a Means to Control Dengue Virus Pathogenesis: Do We Know Enough?
Theodore C. Pierson et al.
ANNUAL REVIEW OF VIROLOGY, VOL 1 (2014)
A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults
Stephen J. Thomas et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Dengue vaccines: recent developments, ongoing challenges and current candidates
Monica A. McArthur et al.
EXPERT REVIEW OF VACCINES (2013)
Challenges in reducing dengue burden; diagnostics, control measures and vaccines
Sai Kit Lam
EXPERT REVIEW OF VACCINES (2013)
Human Monoclonal Antibodies Derived From Memory B Cells Following Live Attenuated Dengue Virus Vaccination or Natural Infection Exhibit Similar Characteristics
Scott A. Smith et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: Their immunity and protective efficacy in mice
Hui Lu et al.
MOLECULAR IMMUNOLOGY (2013)
The Synergistic Effect of Combined Immunization with a DNA Vaccine and Chimeric Yellow Fever/Dengue Virus Leads to Strong Protection against Dengue
Adriana S. Azevedo et al.
PLOS ONE (2013)
New generation humanized mice for virus research: Comparative aspects and future prospects
Ramesh Akkina
VIROLOGY (2013)
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Katie J. Ewer et al.
NATURE COMMUNICATIONS (2013)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Antibody Repertoires in Humanized NOD-scid-IL2Rγnull Mice and Human B Cells Reveals Human-Like Diversification and Tolerance Checkpoints in the Mouse
Gregory C. Ippolito et al.
PLOS ONE (2012)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts
Anderson Paul Kanagaraj et al.
PLANT MOLECULAR BIOLOGY (2011)
Dengue Virus Tropism in Humanized Mice Recapitulates Human Dengue Fever
Javier Mota et al.
PLOS ONE (2011)
Expression of HLA Class II Molecules in Humanized NOD.Rag1KO.IL2RgcKO Mice Is Critical for Development and Function of Human T and B Cells
Rebecca Danner et al.
PLOS ONE (2011)
Next generation dengue vaccines: A review of candidates in preclinical development
Julia Schmitz et al.
VACCINE (2011)
Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
Charmagne G. Beckett et al.
VACCINE (2011)
Modeling Antibody-Enhanced Dengue Virus Infection and Disease in Mice: Protection or Pathogenesis?
Theodore C. Pierson
CELL HOST & MICROBE (2010)
Domain III of the envelope protein as a dengue vaccine target
Maria G. Guzman et al.
EXPERT REVIEW OF VACCINES (2010)
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Wanwisa Dejnirattisai et al.
SCIENCE (2010)
Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance
Stephen J. Thomas et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice
J. Pradeep Babu et al.
VACCINE (2008)
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
H Shimizu et al.
JOURNAL OF VIROLOGY (2004)
分享论文
